Quick answer

Carrier screening checks whether partners carry recessive disease variants (cystic fibrosis, Tay-Sachs, spinal muscular atrophy, and 100+ more in expanded panels). One-in-four affected-child risk materializes only when BOTH carry — knowing beforehand transforms reproductive options.

How recessive inheritance plays out

Carriers (one variant copy) stay healthy; children receiving variant copies from BOTH parents face 25% affected risk per pregnancy. Screening therefore evaluates BOTH partners — one-sided results leave half the equation unknown. Ashkenazi Jewish ancestry carries elevated rates for several pan-ethnic conditions (Tay-Sachs notably); expanded panels democratize detection across ancestries.

Screening tiers

  • ACSG-standard panel: cystic fibrosis, spinal muscular atrophy, fragile-X + ancestry-targeted conditions
  • Expanded panels: 100-300+ genes simultaneously — cost-effective now ($100-400 direct-access era), catching surprises ancestry assumptions miss (everyone's ancestry assumptions fail eventually)

Result pathways

Both carriers of SAME condition: reproductive options expand enormously when known PRE-conception — IVF with embryo testing, donor gametes, prenatal diagnosis preparation, informed acceptance. One carrier: partner testing completes assessment. Neither: residual risk persists (detection rates 90-99%, never 100%) — reassurance with asterisk.

Timing philosophy

Pre-conception screening maximizes optionality; early-pregnancy screening preserves some decisions but compresses timelines. Genetic counseling wraps either pathway — reputable services bundle it; standalone results without counseling invite misinterpretation spirals.

Order this test online

Direct-access laboratory testing — no appointment or doctor visit required. Results delivered as secure PDFs.

We may earn a commission when you order through partner links. Educational content only — never a substitute for professional medical advice.

Frequently asked questions

We're not Jewish — skip Tay-Sachs?

Expanded panels caught non-Ashkenazi Tay-Sachs carriers routinely — ancestry-based testing missed real cases; pan-ethnic screening won the argument.

Positive carrier result — panic appropriate?

Briefly understandable, statistically unnecessary — most carrier findings change NOTHING unless partners match; counseling converts fear into planning.